The Weekly Litigation News Digest is now live. Subscribe now

Methods Of Treating Prostate Cancer - EP3490560

The patent EP3490560 was granted to Janssen Pharmaceutica on Jan 22, 2025. The application was originally filed on Jul 28, 2017 under application number EP17754226A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3490560

JANSSEN PHARMACEUTICA
Application Number
EP17754226A
Filing Date
Jul 28, 2017
Status
Granted And Under Opposition
Dec 20, 2024
Publication Date
Jan 22, 2025
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

SANDOZSep 17, 2025ELKINGTON AND FIFEADMISSIBLE

Patent Citations (2) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS8071623
DESCRIPTIONUS8436185

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents